Critical points in the management of pseudohypoaldosteronism type 1

JCRPE Journal of Clinical Research in Pediatric Endocrinology

Volumn 3, Issue 2, 2011, Pages 98-100

  Güran, Tülay ^a   Degirmenci, Serpil ^a   Bulut, Ipek K ^a   Say, Aysu ^a   Riepe, Felix G ^c   Güran, Ömer ^b  

^a Zeynep Kamil Maternity and Childrens Diseases Training and Research Hospital   (Turkey)

^b SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c UNIVERSITY OF KIEL   (Germany)

Author keywords

Pitfalls; Pseudohypoaldosteronism type 1; Treatment

Indexed keywords

ALDOSTERONE; SODIUM;

ACIDOSIS; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; CLINICAL FEATURE; CLINICAL PRACTICE; ELECTROLYTE DISTURBANCE; FEMALE; HUMAN; HYPERKALEMIA; LABORATORY DIAGNOSIS; NEWBORN; PSEUDOHYPOALDOSTERONISM; SODIUM DEPLETION; SODIUM TRANSPORT; TREATMENT INDICATION;

CATION EXCHANGE RESINS; EPITHELIAL SODIUM CHANNEL; FEMALE; FLUID THERAPY; GENES, RECESSIVE; HUMANS; INFANT, NEWBORN; POINT MUTATION; POTASSIUM, DIETARY; PSEUDOHYPOALDOSTERONISM; SODIUM CHLORIDE, DIETARY; WATER-ELECTROLYTE IMBALANCE;

EID: 79959270537     PISSN: 13085727     EISSN: 13085735     Source Type: Journal    
DOI: 10.4274/jcrpe.v3i2.20     Document Type: Article

References (3)

1. Riepe FG. Clinical and molecular features of type 1 pseudohypoaldosteronism. Horm Res 2009;72:1-9.
2. Urbatsch A, Paller S. Pustular miliaria rubra: a specific cutaneous finding of type 1 pseudohypoaldosteronism. Pediatr Dermatol 2002;19:317-319.
3. Shalev H, Ohali M, Abramson O. Nephrocalcinosis in pseudohypoaldosteronism and the effect of indomethacin therapy. J Pediatr 1994;125:246-248.